Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Akero Therapeutics Inc (NASDAQ: AKRO) was $31.03 for the day, up 4.97% from the previous closing price of $29.56. In other words, the price has increased by $4.97 from its previous closing price. On the day, 0.8 million shares were traded. AKRO stock price reached its highest trading level at $31.1 during the session, while it also had its lowest trading level at $29.1.
Ratios:
Our analysis of AKRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.25 and its Current Ratio is at 17.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on November 18, 2024, initiated with a Buy rating and assigned the stock a target price of $65.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.Cantor Fitzgerald initiated its Overweight rating on September 19, 2023, with a $69 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 15 ’24 when Yale Catriona sold 9,061 shares for $27.73 per share. The transaction valued at 251,274 led to the insider holds 74,158 shares of the business.
Yale Catriona sold 10,000 shares of AKRO for $351,890 on Nov 06 ’24. The Chief Development Officer now owns 74,158 shares after completing the transaction at $35.19 per share. On Nov 06 ’24, another insider, CATRIONA YALE, who serves as the Officer of the company, bought 10,000 shares for $32.74 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 2165869312 and an Enterprise Value of 1484979584.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $37.00, while it has fallen to a 52-week low of $15.32. The 50-Day Moving Average of the stock is 4.71%, while the 200-Day Moving Average is calculated to be 23.08%.
Shares Statistics:
AKRO traded an average of 547.73K shares per day over the past three months and 755970 shares per day over the past ten days. A total of 69.80M shares are outstanding, with a floating share count of 58.43M. Insiders hold about 16.29% of the company’s shares, while institutions hold 96.76% stake in the company. Shares short for AKRO as of 1730332800 were 3820964 with a Short Ratio of 6.98, compared to 1727654400 on 6766665. Therefore, it implies a Short% of Shares Outstanding of 3820964 and a Short% of Float of 5.6399997.
